252 related articles for article (PubMed ID: 29762696)
1. Blocking of an intronic splicing silencer completely rescues IKBKAP exon 20 splicing in familial dysautonomia patient cells.
Bruun GH; Bang JMV; Christensen LL; Brøner S; Petersen USS; Guerra B; Grønning AGB; Doktor TK; Andresen BS
Nucleic Acids Res; 2018 Sep; 46(15):7938-7952. PubMed ID: 29762696
[TBL] [Abstract][Full Text] [Related]
2. Global identification of hnRNP A1 binding sites for SSO-based splicing modulation.
Bruun GH; Doktor TK; Borch-Jensen J; Masuda A; Krainer AR; Ohno K; Andresen BS
BMC Biol; 2016 Jul; 14():54. PubMed ID: 27380775
[TBL] [Abstract][Full Text] [Related]
3. RBM24 promotes U1 snRNP recognition of the mutated 5' splice site in the
Ohe K; Yoshida M; Nakano-Kobayashi A; Hosokawa M; Sako Y; Sakuma M; Okuno Y; Usui T; Ninomiya K; Nojima T; Kataoka N; Hagiwara M
RNA; 2017 Sep; 23(9):1393-1403. PubMed ID: 28592461
[TBL] [Abstract][Full Text] [Related]
4. Antisense oligonucleotides correct the familial dysautonomia splicing defect in IKBKAP transgenic mice.
Sinha R; Kim YJ; Nomakuchi T; Sahashi K; Hua Y; Rigo F; Bennett CF; Krainer AR
Nucleic Acids Res; 2018 Jun; 46(10):4833-4844. PubMed ID: 29672717
[TBL] [Abstract][Full Text] [Related]
5. hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure.
Damgaard CK; Tange TO; Kjems J
RNA; 2002 Nov; 8(11):1401-15. PubMed ID: 12458794
[TBL] [Abstract][Full Text] [Related]
6. Position-dependent effects of hnRNP A1/A2 in SMN1/2 exon7 splicing.
Qiu J; Qu R; Lin M; Xu J; Zhu Q; Zhang Z; Sun J
Biochim Biophys Acta Gene Regul Mech; 2022 Nov; 1865(8):194875. PubMed ID: 36208849
[TBL] [Abstract][Full Text] [Related]
7. Roles for SR proteins and hnRNP A1 in the regulation of c-src exon N1.
Rooke N; Markovtsov V; Cagavi E; Black DL
Mol Cell Biol; 2003 Mar; 23(6):1874-84. PubMed ID: 12612063
[TBL] [Abstract][Full Text] [Related]
8. Weak definition of IKBKAP exon 20 leads to aberrant splicing in familial dysautonomia.
Ibrahim EC; Hims MM; Shomron N; Burge CB; Slaugenhaupt SA; Reed R
Hum Mutat; 2007 Jan; 28(1):41-53. PubMed ID: 16964593
[TBL] [Abstract][Full Text] [Related]
9. Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins.
Zhu J; Mayeda A; Krainer AR
Mol Cell; 2001 Dec; 8(6):1351-61. PubMed ID: 11779509
[TBL] [Abstract][Full Text] [Related]
10. Control of hnRNP A1 alternative splicing: an intron element represses use of the common 3' splice site.
Simard MJ; Chabot B
Mol Cell Biol; 2000 Oct; 20(19):7353-62. PubMed ID: 10982852
[TBL] [Abstract][Full Text] [Related]
11. The prevalent deep intronic c. 639+919 G>A GLA mutation causes pseudoexon activation and Fabry disease by abolishing the binding of hnRNPA1 and hnRNP A2/B1 to a splicing silencer.
Palhais B; Dembic M; Sabaratnam R; Nielsen KS; Doktor TK; Bruun GH; Andresen BS
Mol Genet Metab; 2016 Nov; 119(3):258-269. PubMed ID: 27595546
[TBL] [Abstract][Full Text] [Related]
12. Sensory and autonomic deficits in a new humanized mouse model of familial dysautonomia.
Morini E; Dietrich P; Salani M; Downs HM; Wojtkiewicz GR; Alli S; Brenner A; Nilbratt M; LeClair JW; Oaklander AL; Slaugenhaupt SA; Dragatsis I
Hum Mol Genet; 2016 Mar; 25(6):1116-28. PubMed ID: 26769677
[TBL] [Abstract][Full Text] [Related]
13. hnRNP A1 Regulates Alternative Splicing of Tau Exon 10 by Targeting 3' Splice Sites.
Liu Y; Kim D; Choi N; Oh J; Ha J; Zhou J; Zheng X; Shen H
Cells; 2020 Apr; 9(4):. PubMed ID: 32290247
[TBL] [Abstract][Full Text] [Related]
14. An intron element modulating 5' splice site selection in the hnRNP A1 pre-mRNA interacts with hnRNP A1.
Chabot B; Blanchette M; Lapierre I; La Branche H
Mol Cell Biol; 1997 Apr; 17(4):1776-86. PubMed ID: 9121425
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential and mechanism of kinetin as a treatment for the human splicing disease familial dysautonomia.
Hims MM; Ibrahim EC; Leyne M; Mull J; Liu L; Lazaro C; Shetty RS; Gill S; Gusella JF; Reed R; Slaugenhaupt SA
J Mol Med (Berl); 2007 Feb; 85(2):149-61. PubMed ID: 17206408
[TBL] [Abstract][Full Text] [Related]
16. Phosphatidylserine increases IKBKAP levels in a humanized knock-in IKBKAP mouse model.
Bochner R; Ziv Y; Zeevi D; Donyo M; Abraham L; Ashery-Padan R; Ast G
Hum Mol Genet; 2013 Jul; 22(14):2785-94. PubMed ID: 23515154
[TBL] [Abstract][Full Text] [Related]
17. Cardiac glycosides correct aberrant splicing of IKBKAP-encoded mRNA in familial dysautonomia derived cells by suppressing expression of SRSF3.
Liu B; Anderson SL; Qiu J; Rubin BY
FEBS J; 2013 Aug; 280(15):3632-46. PubMed ID: 23711097
[TBL] [Abstract][Full Text] [Related]
18. EGCG corrects aberrant splicing of IKAP mRNA in cells from patients with familial dysautonomia.
Anderson SL; Qiu J; Rubin BY
Biochem Biophys Res Commun; 2003 Oct; 310(2):627-33. PubMed ID: 14521957
[TBL] [Abstract][Full Text] [Related]
19. Distinct sets of adjacent heterogeneous nuclear ribonucleoprotein (hnRNP) A1/A2 binding sites control 5' splice site selection in the hnRNP A1 mRNA precursor.
Hutchison S; LeBel C; Blanchette M; Chabot B
J Biol Chem; 2002 Aug; 277(33):29745-52. PubMed ID: 12060656
[TBL] [Abstract][Full Text] [Related]
20. Tissue-specific reduction in splicing efficiency of IKBKAP due to the major mutation associated with familial dysautonomia.
Cuajungco MP; Leyne M; Mull J; Gill SP; Lu W; Zagzag D; Axelrod FB; Maayan C; Gusella JF; Slaugenhaupt SA
Am J Hum Genet; 2003 Mar; 72(3):749-58. PubMed ID: 12577200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]